The global biological therapies for cancer market is anticipated to increase by USD 50 十亿直到 2028 年均增长 8.2 根据 Gen Consulting 公司的最新报告.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global biological therapies for cancer market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the biological therapies for cancer industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, 和地区. The global market for biological therapies for cancer can be segmented by product: CAR T-cell therapies, 单克隆抗体, 疫苗. The monoclonal antibodies segment held the largest revenue share in 2021. Biological therapies for cancer market is further segmented by region: 亚太地区, 欧洲, 北美, 世界其他地区 (排). 在这些当中, 北美地区是全球收入最高的地区 2021.

副产品:
– CAR T-cell therapies
– 单克隆抗体
– 疫苗

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The market research report covers the analysis of key stake holders of the global biological therapies for cancer market. Some of the leading players profiled in the report include Amgen Inc., 阿斯利康公司, 百时美施贵宝公司 (电池管理系统), Eli Lilly and Company, F. 罗氏霍夫曼公司, Genmab A/S, Gilead Sciences, 公司, 葛兰素史克公司 (GSK), Janssen Pharmaceuticals, 公司, 默克公司, 诺华国际公司, 辉瑞公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global biological therapies for cancer market.
– To classify and forecast the global biological therapies for cancer market based on product, 地区.
– To identify drivers and challenges for the global biological therapies for cancer market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global biological therapies for cancer market.
– To identify and analyze the profile of leading players operating in the global biological therapies for cancer market.

为什么选择这份报告
– Gain a reliable outlook of the global biological therapies for cancer market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.